Prevalence and Etiological Characteristics of Norovirus Infection in China: A Systematic Review and Meta-Analysis.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
07 06 2023
Historique:
received: 16 05 2023
revised: 04 06 2023
accepted: 04 06 2023
medline: 29 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Norovirus is a common cause of sporadic cases and outbreaks of gastroenteritis worldwide, although its prevalence and the dominant genotypes responsible for gastroenteritis outbreaks remain obscure. A systematic review was conducted on norovirus infection in China between January 2009 and March 2021. A meta-analysis and beta-binomial regression model were used to explore the epidemiological and clinical characteristics of norovirus infection and the potential factors contributing to the attack rate of the norovirus outbreaks, respectively. A total of 1132 articles with 155,865 confirmed cases were included, with a pooled positive test rate of 11.54% among 991,786 patients with acute diarrhea and a pooled attack rate of 6.73% in 500 norovirus outbreaks. GII.4 was the predominant genotype in both the etiological surveillance and outbreaks, followed by GII.3 in the etiological surveillance, and GII.17 in the outbreaks, with the proportion of recombinant genotypes increasing in recent years. A higher attack rate in the norovirus outbreaks was associated with age group (older adults), settings (nurseries, primary schools, etc.) and region (North China). The nation-wide pooled positive rate in the etiological surveillance of norovirus is lower than elsewhere in the global population, while the dominant genotypes are similar in both the etiological surveillance and the outbreak investigations. This study contributes to the understanding of norovirus infection with different genotypes in China. The prevention and control of norovirus outbreaks during the cold season should be intensified, with special attention paid to and enhanced surveillance performed in nurseries, schools and nursing homes from November to March.

Identifiants

pubmed: 37376635
pii: v15061336
doi: 10.3390/v15061336
pmc: PMC10302178
pii:
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Rev Med Virol. 2022 Nov;32(6):e2382
pubmed: 35946340
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
J Gen Virol. 2019 Oct;100(10):1393-1406
pubmed: 31483239
PLoS One. 2016 Apr 26;11(4):e0151219
pubmed: 27115736
PLoS One. 2015 Dec 03;10(12):e0142927
pubmed: 26632843
Clin Infect Dis. 2001 Sep 1;33(5):622-8
pubmed: 11477530
Hum Vaccin Immunother. 2021 Nov 2;17(11):4553-4566
pubmed: 34495811
MMWR Morb Mortal Wkly Rep. 2013 Jan 25;62(3):55
pubmed: 23344699
Nat Commun. 2021 Apr 29;12(1):2464
pubmed: 33927201
Lancet Infect Dis. 2014 Aug;14(8):725-730
pubmed: 24981041
Int J Environ Res Public Health. 2017 Nov 03;14(11):
pubmed: 29099784
Euro Surveill. 2015 Jul 02;20(26):
pubmed: 26159307
PLoS One. 2013 Sep 04;8(9):e72788
pubmed: 24023773
Clin Infect Dis. 2002 Aug 1;35(3):246-53
pubmed: 12115089
BMC Public Health. 2011 May 11;11:297
pubmed: 21569308
Clin Microbiol Rev. 2015 Jan;28(1):134-64
pubmed: 25567225
J Infect. 2017 Sep;75(3):216-224
pubmed: 28633888
PLoS One. 2009 Aug 24;4(8):e6671
pubmed: 19701458
Emerg Infect Dis. 2008 Aug;14(8):1224-31
pubmed: 18680645
Emerg Infect Dis. 2020 Mar;26(3):437-445
pubmed: 32091361
J Clin Virol. 2009 Jan;44(1):1-8
pubmed: 19084472
Lancet Infect Dis. 2018 May;18(5):545-553
pubmed: 29396001
Front Med. 2020 Feb;14(1):1-7
pubmed: 31823287
Jpn J Infect Dis. 2015;68(1):70-4
pubmed: 25702790
PLoS One. 2013 Oct 02;8(10):e75922
pubmed: 24098406
BMC Med Res Methodol. 2008 Aug 19;8:58
pubmed: 18713448
Emerg Infect Dis. 2008 Oct;14(10):1546-52
pubmed: 18826817
J Gen Virol. 2016 Oct;97(10):2620-2632
pubmed: 27543110
N Engl J Med. 2009 Oct 29;361(18):1776-85
pubmed: 19864676
Viruses. 2019 Apr 11;11(4):
pubmed: 30979014
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Ting-Ting Li (TT)

School of Public Health, Guizhou Medical University, Guiyang 550025, China.
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.

Qiang Xu (Q)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.

Mei-Chen Liu (MC)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.
School of Public Health, Anhui Medical University, Hefei 230032, China.

Tao Wang (T)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.

Tian-Le Che (TL)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.

Ai-Ying Teng (AY)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.

Chen-Long Lv (CL)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.

Guo-Lin Wang (GL)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.

Feng Hong (F)

School of Public Health, Guizhou Medical University, Guiyang 550025, China.

Wei Liu (W)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.
School of Public Health, Anhui Medical University, Hefei 230032, China.

Li-Qun Fang (LQ)

School of Public Health, Guizhou Medical University, Guiyang 550025, China.
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH